Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Natural anti-galactose alpha1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts.

Raeder RH, Badylak SF, Sheehan C, Kallakury B, Metzger DW.

Transpl Immunol. 2002 Jun;10(1):15-24.

PMID:
12182460
2.

Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response.

Allman AJ, McPherson TB, Badylak SF, Merrill LC, Kallakury B, Sheehan C, Raeder RH, Metzger DW.

Transplantation. 2001 Jun 15;71(11):1631-40.

PMID:
11435976
3.

IL-12-mediated increases in protection elicited by pneumococcal and meningococcal conjugate vaccines.

Buchanan RM, Briles DE, Arulanandam BP, Westerink MA, Raeder RH, Metzger DW.

Vaccine. 2001 Feb 28;19(15-16):2020-8.

PMID:
11228373
4.

IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection.

Arulanandam BP, Raeder RH, Nedrud JG, Bucher DJ, Le J, Metzger DW.

J Immunol. 2001 Jan 1;166(1):226-31.

5.

A pivotal role for interferon-gamma in protection against group A streptococcal skin infection.

Raeder RH, Barker-Merrill L, Lester T, Boyle MD, Metzger DW.

J Infect Dis. 2000 Feb;181(2):639-45.

PMID:
10669349
6.

Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64.

Raeder R, Harokopakis E, Hollingshead S, Boyle MD.

Infect Immun. 2000 Feb;68(2):744-51.

7.
8.

Role of emm and mrp genes in the virulence of group A streptococcal isolate 64/14 in a mouse model of skin infection.

Boyle MD, Raeder R, Flosdorff A, Podbielski A.

J Infect Dis. 1998 Apr;177(4):991-7.

PMID:
9534973
9.
11.

Detection of streptococcal class I M protein in psoriasis by confocal immunofluorescent microscopy.

Talanin NY, Shelley WB, Raeder R, Shelley ED, Boyle MD.

Acta Derm Venereol. 1997 May;77(3):175-80.

12.

Identification of key gene products required for acquisition of plasmin-like enzymatic activity by group A streptococci.

Christner R, Li Z, Raeder R, Podbielski A, Boyle MD.

J Infect Dis. 1997 May;175(5):1115-20.

PMID:
9129074
13.
14.
16.

Protection of mice from group A streptococcal skin infection by interleukin-12.

Metzger DW, Raeder R, Van Cleave VH, Boyle MD.

J Infect Dis. 1995 Jun;171(6):1643-5.

PMID:
7769309
17.

Characterization of a gene coding for a type IIo bacterial IgG-binding protein.

Boyle MD, Weber-Heynemann J, Raeder R, Podbielski A.

Mol Immunol. 1995 Jun;32(9):669-78.

PMID:
7643859
18.
19.
22.
23.

Identification of two type IIa IgG-binding proteins expressed by a single group A streptococcus.

Otten RA, Raeder R, Heath DG, Lottenberg R, Cleary PP, Boyle MD.

J Immunol. 1992 May 15;148(10):3174-82.

PMID:
1578142
24.

Isolation and partial characterization of a type IV bacterial immunoglobulin binding protein.

Raeder R, Otten RA, Boyle MD.

Mol Immunol. 1991 Jun;28(6):661-71.

PMID:
1861681
25.
26.

Evidence for functional heterogeneity in IgG Fc-binding proteins associated with group A streptococci.

Raeder R, Faulmann EL, Boyle MD.

J Immunol. 1991 Feb 15;146(4):1247-53.

PMID:
1991966
27.

Comparison of albumin receptors expressed on bovine and human group G streptococci.

Raeder R, Otten RA, Boyle MD.

Infect Immun. 1991 Feb;59(2):609-16.

28.

Empirical use of imipenem as the sole antibiotic in the treatment of serious infections.

Freimer EH, Donabedian H, Raeder R, Ribner BS.

J Antimicrob Chemother. 1985 Oct;16(4):499-507.

PMID:
3864777
29.
30.

Occurrence and expression of imipemide (N-formimidoyl thienamycin) resistance in clinical isolates of coagulase-negative staphylococci.

Blumenthal RM, Raeder R, Takemoto CD, Freimer EH.

Antimicrob Agents Chemother. 1983 Jul;24(1):61-9.

31.

Treatment of serious infections with moxalactam.

Ribner BS, Raeder R, Becker TM, Freimer EH.

Am J Med. 1983 Mar;74(3):396-400.

PMID:
6219576
32.

Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.

O'Donnell ED, Freimer EH, Gilardi GL, Raeder R.

Antimicrob Agents Chemother. 1982 Apr;21(4):673-5.

33.

Autoimmune cell-mediated responses: spontaneous responses to syngeneic cells in NZB/NZW F1 mice.

Senitzer D, Cafruny W, Raeder R, Freimer EH.

J Immunol. 1979 Aug;123(2):660-6. No abstract available.

PMID:
458154
34.

Detection of protein A-like substances on haemolytic streptococci prior to use in mixed reverse passive antiglobulin haemagglutination (MRPAH).

Freimer EH, Raeder R, Feinstein A, Herbert J, Gurner BW, Coombs RR.

J Immunol Methods. 1979;31(3-4):219-29.

PMID:
118215
35.

Response of peripheral blood lymphocytes from the (NZB/NZW)F1 mouse to phytohemagglutinin.

Raeder R, Freimer EH, Pansky B, Senitzer D.

Clin Immunol Immunopathol. 1976 Sep;6(2):174-81. No abstract available.

PMID:
1085684

Supplemental Content

Loading ...
Support Center